Hong-kong, Special administrative regions of China

Hong Kong, July 28 A team of researchers has developed an inhalable dry powder formulation of tamibarotene a repurposed drug which has showed broad-spectrum antiviral activity against SARS-CoV-2, MERS-CoV and influenza A H1N1 virus following pulmonary delivery in animal models.Tamibarotene is available as an oral tablet for the treatment of acute promyelocytic leukemia currently marketed in Japan. But when a high dose is administered to compensate for the insufficient lung distribution, toxic side effects are expected because of the extensive systemic exposure.The team, led by the University of Hong Kong (HKUMed), prepared the inhaled dry powder formulation of tamibarotene by spray freeze drying, a particle engineering technique that combines spray freezing and freeze drying to produce particles with excellent aerosol properties for inhalation.The researchers found that a dose of tamibarotene powder delivered by intratracheal administration significantly reduced virus titer and viral RNA load of SARS-CoV-2 in the hamsters' lungs, and the antiviral efficacy was comparable to intratracheally administered remdesivir.The broad-spectrum anti-coronavirus activity of inhaled tamibarotene powder was also demonstrated in MERS-CoV-infected mice model as pre-challenge prophylaxis.Moreover, remarkable anti-influenza activity of tamibarotene powder formulation was demonstrated by the improved survival rate of mice and alleviated disease severity when administered either intratracheally as prophylaxis or intranasally as treatment. The findings have been published online in Advanced Therapeutics."Currently, there is no inhaled powder formulation of antiviral available on the market for Covid-19 treatment. Tamibarotene dry powder with broad-spectrum antiviral activity presents a new strategy for Covid-19 management, especially as prophylaxis and treatment for outpatients when in-patient healthcare cannot be provided," said Jenny Lam, Associate Professor, Department of Pharmacology and Pharmacy, HKUMed."With the favourable safety profile of tamibarotene and based on the findings in the present study, clinical trials evaluating inhaled tamibarotene for its safety and as at-home treatment for Covid-19 could be considered," Lam said.Inhaled powder formulation of broad-spectrum antiviral drugs can be used on an outpatient basis due to the ease of (self-)administration as prevention and treatment for respiratory viral infections, the researchers said.Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Hong-KongFOLLOW

Hong-kong, Latest News

Mumbai, July 29 India's key Indian equity indices made healthy gains on Thursday, following positive global cues. The ... ...

As part of Clean Air Action Plan of the District Administration of Agra, the United Nations Environment Programme (UNEP) and its partners are providing support and technical assistance in the implementation of activities under the Plan. These efforts ...

Equity benchmark indices were in the green zone during early hours on Thursday after three days of selloff as the global mood stabilised following reports that Chinese securities regulator has stepped in to assuage investor concerns over tech crackdo ...

A group of journalists has demanded the Hong Kong police to explain why a city reporter's home was searched and travel documents were confiscated, the International Federation of Journalists (IFJ) informed on Wednesday. ...

India shuttler PV Sindhu on Thursday said the fact that many people consider her a player who takes her game a notch higher in pressure-cooker situations works as a compliment for her. Sindhu's remarks came as the shuttler progressed to the quarter-f ...

Star Indian shuttler PV Sindhu defeated Denmark's Mia Blichfeldt in the Round of 16 match of women's individual event in the Tokyo Olympics here at the Musashino Forest Plaza Court 3 on Thursday. Sindhu defeated Mia Blichfeldt 21-15, 21-13 in just 41 ...

Shuttler PV Sindhu, archer Deepika Kumari, and boxer Pooja Rani stole the show for the Indian contingent on Wednesday in the ongoing Tokyo Olympics, but the women's hockey team disappointed and their road to the knockout stage is now looking difficul ...

Hong Kong, July 28 A team of researchers has developed an inhalable dry powder formulation of tamibarotene ... ...